Arvate, H. R. (2025). Major clinical outcomes of the action of the co-agonist tirzepatide to liraglutide and semaglutide in the treatment of obesity and type 2 diabetes mellitus: a systematic review. International Journal of Nutrology, 18(1). https://doi.org/10.54448/ijn25102